Marksans Pharma Limited announced on 20 Mar 25 that its manufacturing facility in Verna, Goa has received approval from the Australian Therapeutic Goods Administration (TGA). This approval allows the facility to manufacture pharmaceutical formulations in solid dosage forms, including tablets and hard capsules, for the Australian market. The products will be marketed and distributed in Australia through the company's subsidiary, Nova Pharmaceuticals Australasia Pty Ltd.